Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Van Herwaarden MA et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. 2000 Aliment. Pharmacol. Ther. pmid:10759625
Ramirez B and Richter JE Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. 1993 Aliment. Pharmacol. Ther. pmid:8094981
Catnach SM et al. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. 1993 Aliment. Pharmacol. Ther. pmid:8439638
Russo A et al. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. 2004 Aliment. Pharmacol. Ther. pmid:15274670
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Haans JJ and Masclee AA Review article: The diagnosis and management of gastroparesis. 2007 Aliment. Pharmacol. Ther. pmid:18081647
Bai Y et al. Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. 2011 Aliment. Pharmacol. Ther. pmid:21615438
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Emmanuel AV et al. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. 2004 Aliment. Pharmacol. Ther. pmid:15023171
Netzer P et al. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:12182748
Athanasakis E et al. Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. 2002 Aliment. Pharmacol. Ther. pmid:12182757
McCallum RW and Cynshi O Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. 2007 Aliment. Pharmacol. Ther. pmid:17894654
Chen CL et al. Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:11929393
Winstead NS and Wilcox CM Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. 2007 Aliment. Pharmacol. Ther. pmid:17848180
Bell GD et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. 1992 Aliment. Pharmacol. Ther. pmid:1486161
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Annese V et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. 1997 Aliment. Pharmacol. Ther. pmid:9218089
van Erpecum KJ et al. Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. 2000 Aliment. Pharmacol. Ther. pmid:10903008
Chiba T et al. Motilides accelerate regional gastrointestinal transit in the dog. 2000 Aliment. Pharmacol. Ther. pmid:10886053
Minocha A et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. 1995 Aliment. Pharmacol. Ther. pmid:8580273
Landry C et al. Could oral erythromycin optimize high energy continuous enteral nutrition? 1996 Aliment. Pharmacol. Ther. pmid:8971296
Ehrenpreis ED et al. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. 1998 Aliment. Pharmacol. Ther. pmid:9690728
Jameson JS et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. 1992 Aliment. Pharmacol. Ther. pmid:1420750
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Medhus AW et al. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. 2000 Aliment. Pharmacol. Ther. pmid:10651665
Curry JI et al. Review article: erythromycin as a prokinetic agent in infants and children. 2001 Aliment. Pharmacol. Ther. pmid:11328252
Kendall BJ et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9146779
Boecxstaens V et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. 2011 Aliment. Pharmacol. Ther. pmid:21517922
Laine L et al. Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. 1996 Aliment. Pharmacol. Ther. pmid:8791949
Wehrmann T et al. Effect of erythromycin on human biliary motility. 1996 Aliment. Pharmacol. Ther. pmid:8791972
San Pedro de Saenz B et al. FDE to macrolides. 2002 Allergy pmid:11991294
Florido Lopez JF et al. Fixed eruption due to erythromycin. A case report. 1991 Allergy pmid:1826819
Miller KE Diagnosis and treatment of Chlamydia trachomatis infection. 2006 Am Fam Physician pmid:16669564
Constantine PA Antibiotic therapy and serum digoxin toxicity. 1998 Am Fam Physician pmid:9531908
Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. 2012 Am Fam Physician pmid:22335221
Tan HH Antibacterial therapy for acne: a guide to selection and use of systemic agents. 2003 Am J Clin Dermatol pmid:12688836
Taylor GA and Shalita AR Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. 2004 Am J Clin Dermatol pmid:15301572
Ferguson DL et al. Lichenoid lymphocytic vasculitis with a high component of histiocytes. Histogenetic implications in a specified clinical setting. 1989 Am J Dermatopathol pmid:2729528
Rosen RA The use of antibiotics in the initial management of recent dog-bite wounds. 1985 Am J Emerg Med pmid:3970747
Altieri M et al. Antibiotic prophylaxis in intraoral wounds. 1986 Am J Emerg Med pmid:3096345
Paris DG et al. Torsades de pointes induced by erythromycin and terfenadine. 1994 Am J Emerg Med pmid:7945604
Traub SJ et al. Use of pharmaceutical promotility agents in the treatment of body packers. 2003 Am J Emerg Med pmid:14574669
Parker DL et al. Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin. 2010 Am J Health Syst Pharm pmid:20044367
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Erythromycin resistance in Finland declines after reduction in macrolide use. 1997 Am J Health Syst Pharm pmid:9359947
Lestico MR and Smith AD Stevens-Johnson syndrome following erythromycin administration. 1995 Am J Health Syst Pharm pmid:8528839
Horn JR Analysis of purported erythromycin-warfarin interaction. 2010 Am J Health Syst Pharm pmid:20516463
Lilley LL and Guanci R Drug interaction triggers weakness. 1998 Am J Nurs pmid:9556673
Devereux PM and Goldstein EJ Legionnaires' disease: finding answers to the riddle. 1980 Am J Nurs pmid:6898101
Erythromycin use linked to pyloric stenosis. 2000 Am J Nurs pmid:10738394
Koegel L Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum. 1985 Am J Otol pmid:3872601
Sacristán JA et al. Ototoxicity of erythromycin in man: electrophysiologic approach. 1993 Am J Otol pmid:8503495
Kyrmizakis DE et al. QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin. 2002 Sep-Oct Am J Otolaryngol pmid:12239699
Ghidini A et al. Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy. 1999 Am J Perinatol pmid:10772199
Bar J et al. Effect of antibiotic therapy in preterm premature rupture of the membranes on neonatal mortality and morbidity. 2000 Am J Perinatol pmid:11110340
Ogasawara KK and Goodwin TM The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. 1997 Am J Perinatol pmid:9259934
El Younis CM et al. Rapid marked response of severe hyperemesis gravidarum to oral erythromycin. 1998 Am J Perinatol pmid:9890250
Crum NF et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. 2003 Am J Prev Med pmid:12880877
Usiskin SI et al. Retreatment with clozapine after erythromycin-induced neutropenia. 2000 Am J Psychiatry pmid:10831491
Fox KK et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. 2001 Am J Public Health pmid:11392941
Tsevat J et al. Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. 1989 Am J Public Health pmid:2499200
Park HH et al. The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. 2010 Sep-Oct Am J Rhinol Allergy pmid:21244734
Jiang RS et al. Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps. 2012 Jul-Aug Am J Rhinol Allergy pmid:22801017
Bachmann K et al. A study of the interaction between dirithromycin and astemizole in healthy adults. 1997 Feb-Mar Am J Ther pmid:10423595
Cvetanovic I et al. The differential antibacterial and gastrointestinal effects of erythromycin and its chiral isolates. 2006 Jan-Feb Am J Ther pmid:16428922
Sikri V et al. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux. 2004 Nov-Dec Am J Ther pmid:15543082
Dunlop EM Penicillin and the control of syphilis. 1974 Am. Heart J. pmid:4606895
Clark H An evaluation of antibiotic prophylaxis in cardiac catheterization. 1969 Am. Heart J. pmid:5192402
Chennareddy SB et al. Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval. 1996 Am. Heart J. pmid:8800045
Orban Z et al. Erythromycin-induced cardiac toxicity. 1995 Am. J. Cardiol. pmid:7536388
Guelon D et al. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion. 1986 Am. J. Cardiol. pmid:3751946
Devereux RB et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. 1994 Am. J. Cardiol. pmid:7977041
Freedman RA et al. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. 1987 Am. J. Cardiol. pmid:3812231
McComb JM et al. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. 1984 Am. J. Cardiol. pmid:6486045
Deloose E et al. The motilin receptor agonist erythromycin stimulates hunger and food intake through a cholinergic pathway. 2016 Am. J. Clin. Nutr. pmid:26817505
Finegold SM Interaction of antimicrobial therapy and intestinal flora. 1970 Am. J. Clin. Nutr. pmid:4319890
Deane AM et al. Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. 2012 Am. J. Clin. Nutr. pmid:22572649
Bistrian BR The who, what, where, when, why, and how of early enteral feeding. 2012 Am. J. Clin. Nutr. pmid:22552029
Jamis-Dow CA et al. Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. 1997 Am. J. Clin. Oncol. pmid:9391548
Balassoulis G et al. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. 2008 Am. J. Clin. Oncol. pmid:18845999
Tomomasa T et al. Gastrointestinal sounds and migrating motor complex in fasted humans. 1999 Am. J. Gastroenterol. pmid:10022632
Carbonell N et al. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. 2006 Am. J. Gastroenterol. pmid:16771939
Maganti K et al. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. 2003 Am. J. Gastroenterol. pmid:12591038
Janssen P et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. 2013 Am. J. Gastroenterol. pmid:24005344
DiBaise JK et al. Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers. 2001 Am. J. Gastroenterol. pmid:11467630
Jones KL et al. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. 1999 Am. J. Gastroenterol. pmid:10445530
Rayner CK et al. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia. 2000 Am. J. Gastroenterol. pmid:11007223
Koutsoumbi P et al. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors. 2000 Am. J. Gastroenterol. pmid:11151866
Portincasa P et al. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. 2000 Am. J. Gastroenterol. pmid:11151875
Carmagnola S et al. Mechanoreceptors of the proximal stomach and perception of gastric distension. 2005 Am. J. Gastroenterol. pmid:16086705
Moussa F et al. Erythromycin eye ointment: effect on gastrointestinal motility. 2000 Am. J. Gastroenterol. pmid:10710093
Laine L and Jensen DM Management of patients with ulcer bleeding. 2012 Am. J. Gastroenterol. pmid:22310222
Tanaka M et al. Agranulocytosis induced by macrolide antibiotics. 1995 Am. J. Hematol. pmid:7847332
Singer DR et al. Drug hypersensitivity causing granulomatous interstitial nephritis. 1988 Am. J. Kidney Dis. pmid:3354573
Martínez-Maldonado M Postinfectious glomerulonephritis. 2000 Am. J. Kidney Dis. pmid:10636819
Silang R et al. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. 2001 Am. J. Kidney Dis. pmid:11157368
Ross EA and Koo LC Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. 1998 Am. J. Kidney Dis. pmid:9428453

Table of Content